Literature DB >> 6170636

Correlation between RNA synthesis and basal level guanosine 5'-diphosphate 3'-diphosphate in relaxed mutants of Escherichia coli.

P A Lagosky, F N Chang.   

Abstract

Through the use of a new nucleotide extraction procedure, we had previously shown that relaxed mutants of Escherichia coli exhibit a unique response to amino acid starvation (Lagosky, P. A., and Chang, F. N. (1980) J. Bacteriol. 144, 499-508). The basal level amounts of guanosine 5'-diphosphate 3'-diphosphate (ppGpp) in both relA and phenotypically relaxed relA+ rplK (relC) strains were shown to decrease at the onset of amino acid limitation and to remain severely depressed throughout the course of the starvation. Upon resupplementation of amino acid-starved relaxed mutants, the production of ppGpp resumes and results in the temporary overaccumulation of this nucleotide beyond its original basal level amount. We now show that the basal level ppGpp content of relaxed bacteria, as well as its subsequent fluctuations in response to amino acid starvation, is inversely correlated with the initial rates of RNA synthesis in these strains. The ability of ppGpp to control the rate of protein synthesis in relA mutants was also examined. It was observed that ppGpp had no apparent direct effect on the initial rates of protein synthesis in relA mutants. The constant inverse correlation which exists between ppGpp content in relA mutants, and their rates of RNa synthesis provide evidence which indicates that basal level ppGpp synthesis has definite physiological significance. It also suggests that the synthesis of basal level ppGpp might be an absolute requirement needed for normal bacterial growth.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170636

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  mRNA composition and control of bacterial gene expression.

Authors:  S T Liang; Y C Xu; P Dennis; H Bremer
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  Inhibition of protein synthesis transiently stimulates initiation of minichromosome replication in Escherichia coli.

Authors:  M Weinberger; C E Helmstetter
Journal:  J Bacteriol       Date:  1989-07       Impact factor: 3.490

Review 3.  Control of rRNA synthesis in Escherichia coli: a systems biology approach.

Authors:  Patrick P Dennis; Mans Ehrenberg; Hans Bremer
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

4.  Stringent control of replication of plasmids derived from coliphage lambda.

Authors:  G Wegrzyn; P Neubauer; S Krueger; M Hecker; K Taylor
Journal:  Mol Gen Genet       Date:  1991-01

5.  Effect of relA function on the replication of plasmid pBR322 in Escherichia coli.

Authors:  S Lin-Chao; H Bremer
Journal:  Mol Gen Genet       Date:  1986-04

6.  Basal ppGpp level adjustment shown by new spoT mutants affect steady state growth rates and rrnA ribosomal promoter regulation in Escherichia coli.

Authors:  E Sarubbi; K E Rudd; M Cashel
Journal:  Mol Gen Genet       Date:  1988-08

7.  Comparison of DeltarelA strains of Escherichia coli and Salmonella enterica serovar Typhimurium suggests a role for ppGpp in attenuation regulation of branched-chain amino acid biosynthesis.

Authors:  K Tedin; F Norel
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

8.  rpoB mutation in Escherichia coli alters control of ribosome synthesis by guanosine tetraphosphate.

Authors:  R Little; J Ryals; H Bremer
Journal:  J Bacteriol       Date:  1983-05       Impact factor: 3.490

9.  The role of guanosine-3',5'-bis-pyrophosphate in mediating antimicrobial activity of the antibiotic 3,5-dihydroxy-4-ethyl-trans-stilbene.

Authors:  L Sundar; F N Chang
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Control of rRNA and tRNA syntheses in Escherichia coli by guanosine tetraphosphate.

Authors:  J Ryals; R Little; H Bremer
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.